First of Its Kind Tech Targeting FDA Clearance

TriAgenics’ patented dental treatment is designed to stop wisdom teeth from ever forming. It’s a breakthrough with the potential to unlock $25B in new annual revenues for dentists worldwide.

  1. 37 patents protecting breakthrough technology
  2. Leadership from IBM & Align Technology (Invisalign)
  3. $16.5M capital raised to date

Now you have the rare chance to invest before FDA clearance and our commercial launch.

Join waitlist
Looking to finalize your investment? Click below
Sign in

Reserve Shares

Join the waitlist by reserving shares.

Innovation

The End of Wisdom Tooth Surgeries

Our patented, first-of-its-kind procedure for children ages 6-12 is designed to prevent wisdom teeth from ever forming. Instead of referring patients out of office to expensive oral surgeons, any dentist will be able to perform our one-minute, minimally invasive treatment during routine dental visits.

Target Age Range

Ages 6-12
TriAgenics Zero3® medical device setup showing the main touchscreen unit displaying patient info, connected handpiece, patient data card, and foot control, used for minimally invasive wisdom tooth treatment.
Opportunity

Boosting Dentist Profits by $25B/Year

Patients act when it’s already too late, spending $5B/year on painful extraction surgeries that leave them sidelined for weeks. And dentists outsource over 80% of the 5M+ annual procedures. But the number of parents that would pay to avoid surgery is magnitudes higher, with over 24M children ages 6-12 in the U.S. alone. At just 10 procedures per month, our tech could unlock $25B/year in new revenue for global dentist practices.

$5 Billion

U.S. consumers spend more than $5 billion yearly for extractions and related care
Roadmap

From FDA Milestones to Global Expansion

By investing now, you’re joining a proven, veteran team, working diligently to bring this breakthrough tech to market. As we work toward FDA clearance, we’ve got our roadmap laid out for commercialization in the US and abroad.

FDA Clearance.

We are committed to meet all U.S. Food and Drug Administration regulations and guidelines.

Clinical Trials.

We plan to conduct human clinical trials to demonstrate safety and effectiveness.

Commercial Launch.

Post FDA clearance, we first plan to commercially launch to general dentists in the U.S.

Global Expansion

We have secured international patents in Canada, Mexico, Australia, and Europe..

Smiling male doctor wearing glasses and a stethoscope stands beside a happy mother with her two young daughters in a warmly lit medical office.
Business Model

The Ultimate Win-Win For Dentists, Patients and TriAgenics

Rather than having wisdom teeth removed by oral surgeons, family dentists will have a quick preventive-care procedure that prevents wisdom teeth from ever forming. General dentists can potentially increase their annual revenues by $300,000 by treating 10 patients per month. TriAgenics plans to sell its Zero3 surgical kits to dentists for $350 per tooth bud at 75% margins. Similar to the way Invisalign clear braces changed the way people get their teeth straightened, we believe Zero3 TBA will be the way people treat wisdom teeth.

Join Waitlist
How It Works

Our Technology is Designed to Prevent Wisdom Teeth From Forming

Zero3 TBA combines breakthrough science, clinical precision, and real-world practicality to deliver a solution that’s easy on patients, profitable for providers, and built to scale industry-wide.

1

Custom Planning

Dentists identify when wisdom tooth buds begin to form in children ages 6-12. A digital scan is taken to create a custom 3D-printed guide that fits securely in the mouth and locks the handpiece into position. This ensures precise treatment of the targeted tooth bud.

2

Targeted Micro-Ablation

We adapted a proven medical ablation technology, which uses focused energy to deactivate tissue, to be safe, precise, and painless for dental use. TriAgenics’ 3D-printed guide positions the tip of the Zero3 handpiece at the center of a tooth bud. The tip of the handpiece warms the tooth bud, and this prevents a wisdom tooth from ever forming.

3

Designed to be Safe, Easy, and Pain-Free

Using TriAgenics’ specialized treatment kit – which includes a patient-specific guide and single-use handpiece – general dentists can safely perform the procedure in-office, without the need for surgical referral or complex equipment. We’re expecting no incisions, minimal bleeding, and no sutures.

Smiling young girl holding up a dental panoramic X-ray showing her teeth and jaw structure.
TriAgenics Zero3 dental device with attached handpiece, displayed on a reflective surface.
Case Study

An Approach Similar to Align Technology

Align Technology created a new standard of care, reshaping the established orthodontic market, and becoming one of the most successful public dental companies. We’re following a similar blueprint.

New standard of care.

Just as clear aligners are replacing metal braces, Zero3 TBA is designed to replace outdated wisdom tooth extractions with a fast, non-invasive alternative.

Practice-level economics.

Align turned orthodontists and general dentists into active promoters by giving them a recurring revenue stream. Zero3 TBA gives general dentists that same opportunity, keeping wisdom tooth procedures in-house.

Scalable, guided system.

Align Technology’s success relied on clear aligners custom-fit to each patient. TriAgenics uses the same principle: a patient-specific, 3D-printed guide that ensures safe, precise targeting in every case.

Broad IP.

TriAgenics holds a broad patent portfolio — 37 issued U.S. and international patents..

Team

Tested Founders, Engineers, and Dental Leaders

From pioneering medical devices to scaling category-defining dental technologies, this team brings the exact experience needed to make Zero3 TBA the next go-to standard of care.

A man wearing glasses and a blue shirt smiles for the camera.
Leigh Colby, DDS
Cofounder, Chief Clinical Officer
A man with a white shirt and a brown jacket smiling.
Dave Watson
Cofounder, Chief Operating Office
A man wearing a blue shirt and a black jacket is smiling.
David Thrower
Chief Executive Officer